Sort
1,049,261 grants matching “t cell”
Receptor-based developmental and reproductive toxicity of Superfund chemicals
$2,272,428David H Sherr · Boston University Medical Campus · P42 · FY2016 · ES
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$2,272,422Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AG
Identifying the gene networks of insulin resistance: the GENESIPS study
$2,272,407Thomas None Quertermous · Stanford University · U01 · FY2015 · HL
Regulation of Neuroligins and Effects on Synapse Number and Function
$2,272,322Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Neutralizing Antibody & AAV FIX Gene Therapy
$2,272,304Richard J Samulski · Univ Of North Carolina Chapel Hill · P01 · FY2015 · HL
SPORE in Brain Cancer
$2,272,282Duke University · P50 · FY2005 · CA
Sex, Chromosomes, and Immunity in Bladder Cancer
$2,272,271Xue Sean Li · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
$2,272,183George L King · Joslin Diabetes Center · DP3 · FY2016 · DK
DNA Sequencing and FACS Core Facilities
$2,272,032Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,271,960David G Amaral · University Of California At Davis · P50 · FY2021 · HD
Mitochondrial Complex I as a Target for Neuroprotection in AD
$2,271,860Eugenia Trushina · Mayo Clinic Rochester · RF1 · FY2022 · AG
Cancer Center Support Grant
$2,271,814Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2021 · CA
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
$2,271,783Samson T Jacob · Ohio State University · P01 · FY2008 · CA
Harvard-wide Program on Antibiotic Resistance
$2,271,745Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2024 · AI
Capacitative Calcium Entry
$2,271,662James W Putney · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
The Genetics of Uveal Coloboma
$2,271,643Brian Brooks · National Eye Institute · ZIA · FY2025 · EY
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating
$2,271,441Richard Joseph Johnson · University Of Colorado Denver · RC4 · FY2010 · DK
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Entorhinal-hippocampal interactions during progressive memory impairments in mouse models of Alzheimer's disease pathology
$2,271,330Tristan Shuman · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · AG
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma
$2,271,313Angela Nicole Koehler · Massachusetts Institute Of Technology · UM1 · FY2025 · CA
Multifunctional morphogens: patterning precision and mesoderm migration
$2,271,279Idse Joannes Heemskerk · University Of Michigan At Ann Arbor · R35 · FY2025 · GM
Center for Translational Pediatric Research (CTPR)
$2,271,150Alan Jackson Tackett · Arkansas Children'S Hospital Res Inst · P20 · FY2020 · GM
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,270,866Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2023 · AI
Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.
$2,270,783Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2023 · GM
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
$2,270,739Martin P Paulus · Laureate Institute For Brain Research · P20 · FY2019 · GM